ctrl K

Price Alert

AgeX Therapeutics Inc. (AGE)

AMEX: AGE · Real-Time Price · USD

11.10

-1.50 (-11.90%)

At close: Mar 26, 2024, 8:59 PM

AgeX Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.67M	345K	645K	584K
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	10.6M	50K	50K
Other Long-Term Assets	n/a	50K	n/a	n/a
Receivables	n/a	57K	4K	25K
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	2M	352K	1.8M	1.63M
Total Current Assets	5.68M	754K	2.45M	2.23M
Property-Plant & Equipment	1.05M	n/a	n/a	n/a
Goodwill & Intangibles	n/a	607K	738K	870K
Total Long-Term Assets	1.05M	11.21M	788K	920K
Total Assets	6.72M	11.96M	3.24M	3.15M
Account Payables	744K	1.41M	1.03M	771K
Deferred Revenue	n/a	n/a	n/a	70K
Short-Term Debt	n/a	3.67M	7.65M	7.14M
Other Current Liabilities	1.62M	829K	1.4M	1.06M
Total Current Liabilities	2.37M	5.91M	10.08M	8.97M
Long-Term Debt	268K	693K	10.48M	6.06M
Other Long-Term Liabilities	3.58M	n/a	n/a	n/a
Total Long-Term Liabilities	3.85M	693K	10.48M	6.06M
Total Liabilities	6.22M	6.61M	20.56M	15.03M
Total Debt	268K	4.37M	18.12M	13.2M
Common Stock	1K	n/a	4K	4K
Retained Earnings	-44.32M	-131.01M	-116.21M	-105.75M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	641K	5.47M	-17.21M	-11.83M
Total Investments	n/a	10.6M	50K	50K